Followers | 19 |
Posts | 5643 |
Boards Moderated | 0 |
Alias Born | 01/04/2012 |
Friday, January 06, 2017 6:19:35 PM
It appears to be located in Santa Ana, California.
According to Monster's website:
MOLECULAR BIOLOGIST at ANI PHARMACEUTICALS, INC.
Santa Ana, CA 92701
About the Job
ANI Pharmaceuticals, Inc. - Molecular BiologistProven expertise in the design and hands-on experience with conducting the development of ELISA assays. A combination of work from home and work in lab in southern CA with travel to contract labs (as necessary). Experience with cell biology and/or molecular biology experiments is a must (e.g. ELISA, Western blotting, SDS-PAGE, etc.) Ph.D. in molecular or cellular biology, or biochemistry preferably having industry experience in ELISA development.Resumes can be emailed to sherri.bitter@anipharmaceuticals.com , or faxed to the attention of Sherri Bitter 218-634-3660.
jobview.monster.com/v2/job/View?JobID=178186591[tag]Job[/tag
With respect to ANI's website posting ilike the following;
Collaborate exclusively with Research Scientists and Associates of several contract manufacturing labs on multiple projects, while taking personal responsibility for success of assigned tasks and projects.
Certainly looks like additional acquisitions or partnerships coming down the pipe.
Recent ANIP News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/14/2024 09:16:19 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/13/2024 09:30:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2024 01:01:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2024 11:55:35 AM
- ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance • GlobeNewswire Inc. • 11/08/2024 11:50:28 AM
- ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November • GlobeNewswire Inc. • 11/04/2024 09:30:00 PM
- ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET • GlobeNewswire Inc. • 10/30/2024 09:00:00 PM
- ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06% • GlobeNewswire Inc. • 10/25/2024 10:50:54 AM
- ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024 • GlobeNewswire Inc. • 10/24/2024 10:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2024 09:57:46 PM
- ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2% • GlobeNewswire Inc. • 09/26/2024 10:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:03:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 08:50:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 01:13:56 PM
- ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences • GlobeNewswire Inc. • 09/16/2024 12:53:27 PM
- ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences • GlobeNewswire Inc. • 09/16/2024 10:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2024 08:23:15 PM
- ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution • GlobeNewswire Inc. • 09/13/2024 10:50:00 AM
- ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger • Business Wire • 09/11/2024 10:50:00 AM
- ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger • GlobeNewswire Inc. • 09/11/2024 10:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/10/2024 08:44:38 PM
- ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences • GlobeNewswire Inc. • 09/10/2024 06:09:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 12:29:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:21:44 PM
- ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers’ Option to Purchase Additional Notes • GlobeNewswire Inc. • 08/13/2024 08:05:27 PM
North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California • NBRI • Nov 18, 2024 9:00 AM
One World Products Sets New Standards in Sustainability With Strategic Hemp Innovations • OWPC • Nov 18, 2024 7:54 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM